In the present study, we investigated posttranslational regulatory mechanisms downstream of the IL-6/STAT3/FRA1 inflammatory signaling axis that mediate colon cancer stemness and malignancy and explored novel combinatorial therapeutic approaches to target CRC stem and bulk cells. Here, STAT3 is linked to colorectal carcinoma.